Monte Rosa Therapeutics

$17.41 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Monte Rosa Therapeutics

Monte Rosa Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing molecular glues to degrade disease-causing proteins. Monte Rosa Therapeutics serves customers in the United States and Switzerland.

Stock Analysis

last close $19.39
1-mo return -17.3%
3-mo return -45.7%
avg daily vol. 110.49T
52-week high 45.56
52-week low 17.24
market cap. $956M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 86.6%
baraka

Subscribe now for daily local and international financial news

Subscribe